Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0954-2021Class II

BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2...

Becton Dickinson & Co / initiated 2021-01-07 / Terminated / root cause: manufacturing process

Becton Dickinson & Co. began a recall of BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2 Reagents is a real-time RT-PCR test intended for the... on . FDA classified it as Class II and gives the reason as "Some N1 and N2 master mix pouches packaged within the lots of BioGX SARS-CoV-2 Reagents for BD MAX System may be mislabeled. This could result in a kit containing two pouches of N1 master mix or two pouches of N2 master...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0954-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton Dickinson & Co
Product
BioGX SARS-CoV-2 Reagents for BD MAX System Catalog number (REF) 444213. In vitro diagnostic. SARS-CoV-2 Reagents is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal, nasal, mid-turbinate, and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal aspirates obtained from individuals suspected of COVID-19 by their healthcare provider.
Product code
QJR Reagents, 2019-Novel Coronavirus Nucleic Acid
Reason for recall
Some N1 and N2 master mix pouches packaged within the lots of BioGX SARS-CoV-2 Reagents for BD MAX System may be mislabeled. This could result in a kit containing two pouches of N1 master mix or two pouches of N2 master mix, instead of one pouch of each. If laboratory personnel do not notice that both pouches contain tubes with the same color foil seal and use two of the same tubes, there is a low potential for a false negative SARS-CoV-2 result. A false negative SARS-CoV-2 result could lead to an increased risk of disease progression for the patient and additional spread of SARS-CoV-2 if the patient is not quarantined.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On January 12, 2021, BD issued an Urgent Device Correction notice to customers via letters with FedEx tracking. A customer response form is included with the letter that the customer is instructed to complete electronically, email or fax back to BD. Returned response forms will be reconciled with the customer list.
Quantity in commerce
938 kits
Distribution
US nationwide distribution.
Product codes and lots
Catalog Number: 444213,  Lot Numbers: K20-507, K20-508, K20-509, K20-516, K20-517, K21-020, K21-021.  GTIN Number: 00382904442132

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0954-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0954-2021Class IITerminatedVoluntary: Firm initiated